Clinical Trial Update: Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes [NA]

View source ↗

Summary

A completed trial evaluating the effect of metformin on GLP-1 secretion via cholecystokinin-mediated gallbladder emptying in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED